← Back to headlines
AbCellera Anticipates Phase II Data and Secures New Collaborations
AbCellera expects to release topline data for its ABCL635 Phase II trial soon and has added over $110M in upfront cash from new TCE collaborations.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
